Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

“Heads up. On Doximity app--for docs only--most

Message Board Public Reply | Private Reply | Keep | Replies (2)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154987
(Total Views: 531)
Posted On: 04/22/2020 3:23:40 PM
Avatar
Posted By: ClosetInvestor
Re: Nt2innvovate #29176
“Heads up. On Doximity app--for docs only--most docs posting are seeing good results with HCQ in mild disease exactly like Misiu says.”

I’m a member of the app and have been for some time. Great discussion and resources.

I’ll expand upon your statement above by saying that for every doctor that posts a success story related to HCQ, there are doctors who are asking for more extensive data. Most of the doctors posting success stories aren’t mentioning hundreds of patients successfully treated but more in the tens or single digits. I’m not discounting those stories and the discussions they spark, because they’re important, but a proper study is needed. Also, some are doctors from urgent cares and ERs, who don’t conduct a lot of follow-up nor do they have a lot of historical data on the patients they see. We know that the majority of COVID19 patients will clear the virus themselves without treatment, so HCQ, in most cases, isn’t needed. Many of the patients treated by these doctors no doubt fall into this category and that’s why we need a larger study to better analyze how patients respond.

I’m regards to leronlimab, the drug has been mentioned on the app, mostly under threads about other drugs or discussions on COVID treatments. I’m waiting for the NJM article regarding leronlimab to start a larger discussion, but there doctors on the app spreading the word.


(2)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us